drugset / Trial / NCT00004359

Phase II Pilot Study of Extracorporeal Phototherapy for Epidermolysis Bullosa Acquisita

NCT00004359

Treatment

Summary

OBJECTIVES: I. Evaluate immunomodulation with extracorporeal photochemotherapy (ECP) in patients with epidermolysis bullosa acquisita. II. Investigate the effect of ECP on lymphocyte activity.

Timeline

Start
1996-02
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Background Methoxsalen Other / unclassified Oral